IPC To Utilise PvPI ADR Data For Patient Safety Through Artificial Intelligence

PSM News /

Mumbai, 25 July 2019:

 

With the Centre’s mandate to analyse Adverse Drug Reaction (ADR) data effectively to address patient safety issues in India, the Ghaziabad-based Indian Pharmacopoeia Commission (IPC) is planning to utilise Pharmacovigilance Programme of India (PvPI) ADR data through artificial intelligence (AI) in the coming five years time.

 

To enhance the quality and quantity of ADR data, IPC has recently collaborated with Centre for Cellular and Molecular Biology (CCMB) Hyderabad, Institute of Microbial Technology (IMTech) Chandigarh and Punjab University.

 

CCMB is an Indian biotechnology research establishment located in Hyderabad that operates under the aegis of the Council of Scientific and Industrial Research (CSIR). CCMB is a designated "Center of Excellence" by the global molecular and cell biology network, United Nations Educational, Scientific and Cultural Organization (UNESCO).

 

Established in 1984, IMTech is one among the chain of 38 national laboratories, 6 units and 39 outreach centres of CSIR.

 

Further to conceive a broader platform for raising standards of patient safety through post marketing surveillance of drugs and medical devices as part of the PvPI, IPC has recently collaborated with Quality Council of India (QCI) and Indian Council of Medical Research (ICMR) also.

 

In order to strategise collection and analysis of quality ADR data for patient safety, IPC has also held talks with Benaras Hindu University (BHU) and Indian Institute of Technology (IIT), Varanasi.

 

Plans are also afoot to integrate PvPI with Ayushman Bharat-National Health Protection Scheme (AB-NHPS) for enhancing patient safety of 50 crore insurers covered under the scheme.

 

This comes at a time when the government has envisaged setting up of 22 more ADR monitoring centres (AMCs) to expand the outreach of PvPI. Central Drugs Standard Control Organisation (CDSCO) had initiated PvPI in July 2010 with Ghaziabad-based IPC as the National Co-Ordinating Centre (NCC).

 

As of today, 3 lakh ADR data has been generated and this will further get enhanced with setting up of more AMCs which currently stands at 270.

SOURCE : Pharmabiz